NOVARTIS

0:01:42

Novartis Access Defined

1:13:57

Novartis Campus Lecture - RNA Revolution: A Conversation with Nobel Prize winner Katalin Karikó

0:24:07

Novartis CEO Vas Narasimhan on The David Rubenstein Show

0:01:58

Novartis Raises Outlook After Sandoz Generics Spinoff

0:02:36

Introducing the Novartis Declaration for Patients

0:01:09

Novartis ESG Investor Day 2021: 6 key takeaways

0:02:10

Why Novartis is focusing on access to innovative medicines

0:01:10

The Novartis Biome - a catalyst for impactful digital collaborations

0:00:59

Novartis Oncology - BOLD Science. Transforming Lives. Striving For Cures.

0:00:39

Machine learning is changing the way we do science at Novartis

0:03:04

A look inside the Genomics Institute of the Novartis Research Foundation

0:01:37

Corporate responsibility at Novartis

0:02:03

How are core Therapeutic Areas central to Novartis strategy?

0:00:30

Novartis Financial Results Q3 2021

0:03:57

Clinical Trial Experiences: Novartis Respiratory Development, Linda Armstrong

0:00:46

Novartis areas of focus

0:00:39

Novartis in 360 Ɩ See how robots aid drug discovery

0:04:17

Novartis transformation into a pure-play Innovative Medicines company

0:00:20

Novartis in 360 Ɩ Experience collaboration in action

0:03:52

Novartis Full Year Results 2019

0:02:16

How does Novartis create value for stakeholders and society?

0:00:58

Manufacturing CAR-T Cell Therapies: The Novartis Commitment to Patients

0:01:50

Novartis 2025 Super Bowl Commercial Highlights Breast Screening Importance

0:00:44

Ending the pandemic – How Novartis supports the global vaccine supply